fbpx

Stage IV Renal Cell Cancer- IV Alpha Lipoid Acid, Low-Dose Naltrexone

Share Button

After only a few treatments of IV α-lipoic acid and IV vitamin C, his symptoms (renal cell carcinoma) began to improve…

While I think anecdotal evidence opens up cancer patients to only part of any success story I am writing about the example linked and excerpted below because the renal cell carcinoma patient below was given the same diagnosis that I was…basically that there was little hope with conventional therapies. And while we each have very different cancers, we were both end-stage… and here we are today.

Let me be direct. I think that cancer patients must begin their search with conventional cancer therapies. The RCC patient discussed below had stage 4 RCC cancer that had spread/metastasized. He had few options. Further, there is enough research available to give credibility to IV vitamin C, IV ALA, and LDN.

 

I am both a cancer survivor and cancer coach. I work with cancer patients and survivors to research and identify both conventional and evidence-based non-conventional therapies such as the therapies discussed below.

If you have been diagnosed with RCC and would like to learn more about your therapy options please scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol

“In this case report, we describe the treatment of a 64-year-old male patient diagnosed with metastatic renal cell carcinoma (RCC) in June of 2008. In spite of a left nephrectomy and the standard oncological protocols, the patient developed a solitary left lung metastasis that continued to grow.

He was informed that given his diagnosis and poor response to conventional therapy, any further treatment would, at best, be palliative

An integrative program—developed by one of the authors using

  • intravenous (IV) α-lipoic acid,
  • IV vitamin C,
  • low-dose naltrexone, and
  • hydroxycitrate, and
  • a healthy lifestyle program—was initiated.

From August 2010 to August 2015, the patient’s RCC with left lung metastasis was followed closely using computed tomography and positron emission tomography/computed tomography imaging. His most recent positron emission tomography scan demonstrated no residual increased glucose uptake in his left lung. After only a few treatments of IV α-lipoic acid and IV vitamin C, his symptoms began to improve, and the patient regained his baseline weight. His energy and outlook improved, and he returned to work. The patient had stable disease with the disappearance of the signs and symptoms of stage IV RCC, a full 9 years following diagnosis, with a gentle integrative program, which is essentially free of side effects. As of November 2017, the patient feels well and is working at his full-time job.

 

 

Leave a Comment:

12 comments
Add Your Reply